
Research
ROARing at the Cochrane Symposium
The Roundtable On Arthritis Research (ROAR) was recognized by the folks at Cochrane as an innovative approach to knowledge translation this past year. An invitation to present a poster at the 5th Annual Cochrane Symposium was extended to members of the Consumer Advisory Board of the Arthritis Research Centre of Canada. Have a look .
Childhood Arthritis Survey Results: We asked and you responded
In March 2006, a survey was sent to the CAPA membership to determine issues of importance. The survey results have been tabulated and with the year coming to a close, the Childhood Arthritis Committee would like to share the results with you.
From Research to Practice: Patients Getting a Grip on Arthritis Workshop
What happens to arthritis research, you might ask, after it has been published? One research project that caught CAPA members’ attention was the recent People Getting a Grip on Arthritis Workshop.
Arthritis health care: Are you playing or passing the ball?
Consumers are the voice of those living with arthritis and those directly affected by system and policy decisions. They have the potential to ensure more accessible and acceptable health services, and ultimately improve health and quality of life.
OMERACT: Research, debate and outcomes
What is the best way to measure whether a treatment works or not? What should scales and questionnaires measure? Pain? Function? Stiffness? Joint tenderness? Fatigue?
An offer you can’t refuse?
Everyone has been asked to 'contribute their opinions' to a survey, frequently at dinnertime. Sometimes we like to be asked, most of the time it's a time-wasting nuisance, and with ever-increasing frequency – responding is downright dangerous.
Clinical Trials: What the patient participant needs to know
As patients we are never far from science in its various forms. It's natural then that we should pay close attention to the nightmarish scenario created in the UK by the Phase I clinical trial for a type of monoclonal antibody developed as a potential treatment for some autoimmune diseases.
PTA - Your voice can influence policy decisions
Post-Traumatic Arthritis (PTA) falls into the medical category of secondary Osteoarthritis (OA). Unlike primary OA, its cause is known.
Looking for reliable information ...
The Cochrane Library and Cochrane products are reliable sources of medical information about treatments for any disease or condition because they are produced according to high standards to avoid biased or false information.
Research scientists begin investigation into multifactorial causes of arthritis
A team of national and international collaborators from over a dozen disciplines armed with astounding new technology and inspired by patients expect to make dramatic progress much sooner than most might imagine into effective arthritis prevention strategies.


